Endocrinology

ACTIVE STUDIES NON-RECRUITING: • CORT125134-452 – Open-Label Extension Trial For Cushing Syndrome An Open-Label Extension Study of the Safety of Relacorilant (CORT125134) in the Treatment of the Signs and Symptoms of Endogenous Cushing Syndrome. Those meeting the eligibility criteria will receive trial-related procedures and the study medication [...]